%0 Journal Article %A Jordan Douglas %A Jemma L. Geoghegan %A James Hadfield %A Remco Bouckaert %A Matthew Storey %A Xiaoyun Ren %A Joep de Ligt %A Nigel French %A David Welch %T Real-time genomics to track COVID-19 post-elimination border incursions in Aotearoa New Zealand %D 2021 %R 10.1101/2021.05.13.21257194 %J medRxiv %P 2021.05.13.21257194 %X There have been thirteen known COVID-19 community outbreaks in Aotearoa New Zealand since the virus was first eliminated in May 2020, two of which led to stay-at-home orders being issued by health officials. These outbreaks originated at the border; via isolating returnees, airline workers, and cargo vessels. With a public health system informed by real-time viral genomic sequencing which typically had complete genomes within 12 hours after a community-based positive COVID-19 test, every outbreak was well-contained with a total of 225 community cases, resulting in three deaths. Real-time genomics were essential for establishing links between cases when epidemiological data could not, and for identifying when concurrent outbreaks had different origins. By reconstructing the viral transmission history from genomic sequences, here we recount all thirteen community outbreaks and demonstrate how genomics played a vital role in containing them.Summary The authors recount the role of real-time viral genomics in containing the COVID-19 community outbreaks of Aotearoa New Zealand.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by the New Zealand Ministry of Business, Innovation and Employment and a contract from the Health Research Council of New Zealand (20/1018). Genomic sequencing was partially funded by the New Zealand Ministry of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSequence data available on GISAID %U https://www.medrxiv.org/content/medrxiv/early/2021/05/17/2021.05.13.21257194.full.pdf